Related Experiment Video
Updated: Aug 17, 2026

Whole Body Vibration Methods with Survivors of Polio
Published on: October 17, 2018
Results of a clinical study of polio vaccine: the Buffalo experience
1Division of Infectious Diseases, State University of New York School of Medicine, Buffalo 14222.
Insights
This study compared poliovirus vaccine schedules in infants. Combination schedules using inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine (OPV) showed promising antibody responses.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Poliovirus remains a global health concern, necessitating effective vaccination strategies.
- Understanding the immunogenicity of different poliovirus vaccine schedules is crucial for disease eradication efforts.
Purpose of the Study:
- To evaluate and compare the antibody responses in infants immunized with different schedules of oral poliovirus vaccine (OPV) and inactivated poliovirus vaccine (IPV).
Main Methods:
- 123 infants received one of four trivalent poliovirus vaccine schedules: OPV-OPV-OPV, IPV-IPV-IPV, IPV-OPV-OPV, or IPV-IPV-OPV.
- Serum-neutralizing, nasopharyngeal-neutralizing, and nasopharyngeal IgA antibodies were measured.
Main Results:
- Nearly all infants developed serum-neutralizing antibodies regardless of the vaccine schedule.
- Combination schedules (IPV-OPV-OPV and IPV-IPV-OPV) elicited the highest antibody titers against specific poliovirus serotypes.
- Local mucosal immune responses (nasopharyngeal antibodies) were robust across most groups.
Conclusions:
- Combination IPV and OPV schedules appear to be ideal for inducing comprehensive poliovirus immunity in infants.
- The feasibility of implementing combination schedules in diverse populations, like the United States, requires further investigation.
Abstract:
Serum-neutralizing, nasopharyngeal-neutralizing and nasopharyngeal IgA antibodies were determined in 123 infants immunized with either live (oral) poliovirus vaccine (OPV-OPV-OPV) (Group A), inactivated poliovirus vaccine (IPV-IPV-IPV) (Group B) or combinations of the two trivalent poliovirus vaccines: IPV-OPV-OPV (Group C) or IPV-IPV-OPV (Group D). Nearly 100% of individuals formed serum-neutralizing antibodies. The highest geometric mean titer of antibody to polioviruses 1, 2 and 3 occurred in groups D, C and B, respectively. Local neutralizing and IgA antibody responses were detected in 41 to 88% and 75 to 100%, respectively. Peak geometric mean titer of nasopharyngeal antibodies differed minimally between immunization groups. Based on these data, it appears that a vaccine schedule with the combination of IPV and OPV would be ideal. It is uncertain whether a combination schedule is feasible in a highly mobile and heterogeneous population, such as that found in the United States.
Related Concept Videos
Chickenpox
Poliomyelitis

